Simple ion therapy faces human trials after ten years of preparation.
More than a decade of research hinting that magnesium supplements might boost your brain power is finally being put to the test in a small clinical trial.
The research, led by biopharmaceutical company Magceutics of Hayward, California, began testing the ability of its product Magtein to boost magnesium ion (Mg2+) levels in the brain earlier this month. The trial will track whether the ions can decrease anxiety and improve sleep quality, as well as following changes in the memory and cognitive ability of participants. But critics caution that the trial in just 50 people is too small to draw definitive conclusions.
Neuroscientist Guosong Liu of the Massachusetts Institute of Technology in Cambridge, who founded Magceutics, plans eventually to test whether Magtein can be used to treat a wider range of conditions, including attention deficit hyperactivity disorder (ADHD) and Alzheimer’s disease. But Liu knows that it will be difficult to convince other scientists that something as simple as a magnesium supplement can have such profound effects. It is almost “too good to be true”, he says.
Many scientists contacted by Nature agreed with that sentiment. One clinical researcher cautioned against “over-excitement about a magic drug for a major disorder”. And others wonder whether the study will even be able to prove anything conclusively. “I am very sceptical that the proposed trial will provide the answer to the question being tested,” says Stephen Ferguson, a biochemist at the University of Western Ontario in London, Ontario.
Testing times
It is a crucial moment for Liu, who so far has mostly been testing his product in rats — and in himself. In 1999 he was part of a team that showed, in a well-known ‘smart mouse’ study, that memory in mice could be improved by overexpressing the NMDA receptor 2B (NR2B) in the brain, thereby strengthening synaptic connections. In 2004, Liu’s team showed that magnesium had a key role in these synaptic changes. In 2010, he showed that in rats, pumping up levels of magnesium in the brain helped to improve long- and short-term memory.
Other researchers have found that high doses of magnesium improved memory function in old rats. And research in humans has shown that oral magnesium supplements in aged patients increases the duration of deep sleep, and decreases levels of the stress hormone cortisol.
But it has been difficult to build on these studies, because the pharmaceutical industry is unenthusiastic about funding research into an ion that is freely available and thus unpatentable, says Harald Murck, a neuroscientist at the Psychiatric Clinic of the Philipps University of Marburg, Germany.
When Murck was based at the Max Planck Institute of Psychiatry in Munich, Germany, he carried out research in humans that suggested high levels of intravenous magnesium could have a beneficial effect on cognitive function6. “The challenge here is to find a compound which gets the magnesium in the brain to have these physiological effects,” says Murck.
Brain boost
The Magtein compound was designed to solve the problem of delivering the ion to the brain. The product contains magnesium threonate, in which the metal ion is paired with a low-molecular-weight metabolite of vitamin C that is already present in the brain. Tests have shown that the compound boosts levels of magnesium in rats’ brains by 15% after 24 days3.
Liu adds that he and some friends have been taking Magtein and have found that it increases magnesium levels in their bodies by 50%. Despite the lack of clinical-trial evidence, roughly 100,000 people in the United States are already taking the compound as a supplement that is sold by several different companies, all supplied by Magceutics.
In his double-blind study, Liu will give the compound to 25 people with “greater than normal anxiety”, and a placebo to another 25 with the same condition. But Ferguson cautions that the trial is “far too small to provide any statistical power for analysis”, and that several thousand patients would need to be studied to provide convincing evidence.
Liu agrees that future trials will need to be larger, but hopes that positive results in his trial will be enough to justify expanding the research. Based on promising results from animal studies and tests in three patients, he is planning a trial to test Magtein’s effects on Alzheimer’s disease by the end of the year.
Psychiatry researcher Craig Surman at Harvard Medical School in Boston, Massachusetts, is planning a collaboration with Liu to study Magtein’s effect on ADHD. “We have medications that treat ADHD and some aspects of cognitive function, but there are some parts of brain function that we don’t have evidence-based interventions for,” says Surman. “If it works with low risk, it opens up a whole new mode of supporting people with cognitive challenges.”

Last year, global surveillance resulted in partial sequences from just 160 H5N1 isolates being submitted to GenBank, the main repository of such data (see
Humans may have played a significant part in the sudden disappearance of rainforests from Central Africa, according to a study published online in Science. The work contradicts the prevailing view that the expansion of farming practices on the continent was made possible by the increased incidence of long, severe dry spells that destroyed vast tracts of rainforest.



ESA’s Mars Express has returned strong evidence for an ocean once covering part of Mars. Using radar, it has detected sediments reminiscent of an ocean floor within the boundaries of previously identified, ancient shorelines on Mars.
“MARSIS penetrates deep into the ground, revealing the first 60–80 metres of the planet’s subsurface,” says Wlodek Kofman, leader of the radar team at IPAG.
A spider’s web catches flies. But the cosmic web depicted in the winning poster snares galaxies. Cosmologist Miguel Angel Aragon-Calvo of Johns Hopkins University in Baltimore, Maryland, and colleagues illustrate how an invisible network of matter creates space’s familiar features: “This poster is [intended] to show the relationship between galaxies and the environment where they live,” he says.
Not all good science visualizations highlight the beauty of the natural world. Take this illustration by Ivan Konstantinov and colleagues at the Russia-based group Visual Science. His team drew on existing scientific information to depict the 3D structure of the Ebola virus, responsible for fatal outbreaks of hemorrhagic fever throughout much of Africa.
Cancer cells get the monster movie treatment. If Emiko Paul of Echo Medical Media’s illustration of breast cancer cells looks like something out of an H. P. Lovecraft short story, it’s no accident. “We wanted to show something that was dramatic and very active,” Paul says.
Mathematicians discover their hippie sides. Forgoing long strings of digits and variables, researchers at the Free University of Berlin have taken a tie-dye approach to visualizing math equations. This illustration represents one example of a complex function. Such functions are mathematical relationships that incorporate both real numbers and what experts call imaginary numbers, such as the square root of −1.
rage. Textbook graphics are not catching on. In this illustration, Andrew Noske of the National Center for Microscopy and Imaging Research at the University of California, San Diego, and colleagues create a visualization of mitosis that hops off the page.
No, this photograph doesn’t depict alien slugs stripped from a science-fiction film—just the surface of a young cucumber. It’s a new perspective on an old vegetable. To take this close-up, vibrant shot, photographer Robert Belliveau employed a polarizing microscope. Unlike normal light microscopes, which use unpolarized light, these zooming tools adopt plane-polarized light and record the refraction of light as it passes through small objects to produce a sharp, colorful image.
This landscape, which looks like a red-rock bluff straight out of Utah, isn’t a geologic feature. Instead, it’s a nanostructured material made from ultrathin layers of titanium-based compounds and seen under an electron microscope.